Articles published by Merck & Co., Inc.
Merck to Present at the 4th Annual Evercore ISI HealthCONx Conference
November 24, 2021
Merck Completes Acquisition of Acceleron Pharma Inc.
November 22, 2021
Merck Completes Tender Offer to Acquire Acceleron Pharma Inc.
November 19, 2021
Merck and Ridgeback’s Molnupiravir, an Oral COVID-19 Antiviral Medicine, Receives First Authorization in the World
November 04, 2021
Merck Announces Third-Quarter 2021 Financial Results
October 28, 2021
CDC ACIP Unanimously Votes to Provisionally Recommend Merck’s VAXNEUVANCE™ (Pneumococcal 15-valent Conjugate Vaccine) in Series with PNEUMOVAX ® 23 (Pneumococcal Vaccine Polyvalent) as an Option for Pneumococcal Vaccination in Appropriate Adults
October 20, 2021
Merck Begins Tender Offer to Acquire Acceleron Pharma Inc.
October 12, 2021
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following